VKH
VYNT

Virtu KCG Holdings’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Virtu KCG Holdings’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-166
Closed -$102K – 3638
2017
Q1 		$102K Buy
+166
New +$59.1K ﹤0.01% 2676
2016
Q2 		– Sell
-74
Closed -$31K – 3435
2016
Q1 		$31K Sell
74
-80
-52% -$29.9K ﹤0.01% 2539
2015
Q4 		$76K Buy
+154
New +$111K ﹤0.01% 3065
2015
Q1 		– Sell
-91
Closed -$91K – 4037
2014
Q4 		$91K Buy
+91
New +$91.2K ﹤0.01% 3262

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Virtu KCG Holdings's VYNT Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2017, closing a stake of 166 shares — an estimated $102K sold.

Virtu KCG Holdings first reported a position in VYNT in Q4 2014 and held it in 4 quarters. The position peaked at $102K in Q1 2017. 28 funds tracked by Wall St. Rank hold VYNT as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 166 Vyant Bio, Inc. Common Stock shares in Q2 2017, an estimated $102K.
  • Virtu KCG Holdings first reported a position in Vyant Bio, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
  • Virtu KCG Holdings's Vyant Bio, Inc. Common Stock position peaked at $102K in Q1 2017.
  • 28 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.